Dr. Wesley Sassaman, DNP, MSN-NE, MPH, MBA, FNP-C, CARN-AP
Embarking on the journey to alcohol recovery is a courageous step towards reclaiming your life, yet it often comes with its own set of challenges. Among the most common hurdles faced are brain fog, mood swings, and memory issues—symptoms that can make the path to healing seem daunting. These experiences are a natural part of the recovery process, stemming from the brain’s adjustment to life without alcohol. Understanding these challenges is crucial in navigating the journey, as it empowers you to embrace the changes with patience and self-compassion. This blog aims to explore these facets of recovery, offering insights and hope to those walking this path, reminding you that with time and support, a brighter, clearer future is within reach.
What to Expect
Recovering from long-term alcohol use can present a series of challenges, particularly when it comes to cognitive clarity and emotional stability. It's common to experience "brain fog," emotional ups and downs, and memory issues during this time. These experiences are part of the journey and understanding them can help you feel more in control.
What is Brain Fog?
Brain fog is a term used to describe a feeling of mental cloudiness or confusion. You might find it difficult to focus, remember things, or think clearly. This happens because alcohol can cause changes in your brain’s structure and function, affecting areas responsible for memory and concentration.
Emotional Ups and Downs
As your brain adjusts to life without alcohol, you might notice fluctuations in your emotions. It's normal to feel a range of emotions, from irritability to sadness, as your body and mind adapt. These emotional changes are part of the healing process as your brain chemistry stabilizes.
Memory Issues
You may also experience memory difficulties. Alcohol can disrupt the pathways in your brain needed for forming and recalling memories. These changes might persist for a while, but understanding that they are part of recovery can be reassuring.
Why Do These Symptoms Occur?
During long-term alcohol use, the brain goes through several changes. It affects neurotransmitter systems, causing imbalances that can linger even after stopping alcohol. Additionally, alcohol can lead to inflammation and damage to brain cells, affecting cognitive functions. However, the brain has an incredible ability to heal and adapt through a process known as neuroplasticity.
Be Patient with Yourself
Remember, recovery is a journey, and it takes time. The first year of abstinence involves significant changes, both physically and emotionally. It's important to be patient and kind to yourself during this process. Take each day as it comes and focus on self-care practices that support your well-being.
The Road to Healing
Despite the challenges, there's hope. The brain is resilient and capable of healing over time. By understanding what's happening in your body, you can better manage your expectations and develop coping strategies that work for you. Surround yourself with support, stay informed, and trust in your ability to recover. With patience and perseverance, you will navigate this journey successfully.
What to Expect in your First Year
When a patient stops long-term alcohol use, they can expect a range of adverse side effects over the first year of abstinence. These effects can vary in intensity and duration, impacting both physical and psychological health. The recovery process is complex and involves several stages, with significant changes occurring in the first few months. Understanding these changes can help patients and healthcare providers manage expectations and develop effective coping strategies.
Month 1-3: Acute Withdrawal and Initial Recovery
Alcohol Withdrawal Seizures (AWS): Patients may experience AWS, which are a common complication of alcohol withdrawal. The risk of AWS is higher in individuals with a history of seizures or skull fractures(Sansone et al., 2023).
Neuropsychological Recovery: Initial improvements in basic processing speed and working memory can occur within the first few months(Powell et al., 2024).
Physical Symptoms: Common physical symptoms include increased tiredness, dry mouth, and reduced mobility("Adverse Effects, Smoking, Alcohol Consumption, and Quality of Life during Long-Term Oxygen Therapy: A Nationwide Study", 2022).
Month 4-6: Continued Recovery and Adjustment
Cognitive Improvements: Recovery in attention, executive function, and memory continues, although some functions like verbal fluency may not be impaired at baseline(Powell et al., 2024).
Emotional Wellbeing: There is a decrease in negative emotionality, and improvements in psychological health begin to manifest( Rubio et al., 2023).
Social and Relationship Dynamics: Patients may experience changes in social relationships, which can impact their recovery process(Rubio et al., 2023).
Month 7-12: Long-term Recovery and Stabilization
Quality of Life: Significant improvements in quality of life and psychological wellbeing are observed, although full recovery in some areas may take longer(Rubio et al., 2023).
Risk of Relapse: The risk of AWS relapse decreases, but remains a concern for some patients, particularly those with a history of seizures(Sansone et al., 2023).
Sustained Harm from Others' Drinking: Patients may still experience harm from others' drinking, which can affect their recovery(Sundin et al., 2023).
Take home: While the first year of abstinence from alcohol can be challenging, it is also a period of significant recovery and improvement in various aspects of life. However, the persistence of certain adverse effects and the risk of relapse highlight the need for ongoing support and monitoring. Additionally, the recovery process can be influenced by factors such as gender, social relationships, and the severity of initial harm experienced from alcohol use(Sundin et al., 2023) (Rubio et al., 2023).
Expect and See Improvements
Cognitive improvements in patients between months four and six of alcohol abstinence are characterized by significant enhancements in various cognitive domains. During this period, patients typically experience recovery in executive functions, memory, processing speed, and visuospatial abilities. These improvements are attributed to the cessation of alcohol's neurotoxic effects and the brain's natural recovery processes.
Executive Function and Memory
Studies indicate that executive functions, such as planning and problem-solving, show marked improvement after six months of abstinence. This is evidenced by better performance on tests like the Trail Making Test-B (TMT-B) (Endreddy et al., 2023) (Clergue-Duval et al., 2022).
Memory, particularly short-term and recent memory, also improves significantly. Patients demonstrate enhanced verbal memory and recall abilities, as shown by increased scores on memory assessments (Endreddy et al., 2023) (Ros-Cucurull et al., 2018).
Processing Speed and Visuospatial Abilities
Processing speed, which is often impaired in alcohol-dependent individuals, shows notable recovery. Improvements in this domain are linked to the repair of white matter lesions and enhanced oligodendrocyte function, potentially facilitated by medications like Memantine (Leong et al., 2022).
Visuospatial abilities, crucial for tasks involving spatial awareness and visual recognition, also recover during this period. Patients exhibit better performance in tasks requiring spatial processing and visual recognition (Endreddy et al., 2023) (Ros-Cucurull et al., 2018).
Neuropsychological Assessments and Tools
The Montreal Cognitive Assessment (MoCA) is frequently used to measure cognitive improvements, with significant score increases observed in patients after six months of abstinence (Pelletier et al., 2016).
Other neuropsychological tests, such as the Digit Span Test and Digit Vigilance Test, further confirm improvements in attention and working memory (Endreddy et al., 2023).
Take home: While significant cognitive improvements are observed between months four and six of abstinence, it is important to note that the degree of recovery can vary based on individual factors such as age, baseline cognitive impairment, and the presence of other health conditions. Additionally, some cognitive domains may require longer periods of abstinence for full recovery, and ongoing cognitive rehabilitation may be beneficial for sustained improvement (Ros-Cucurull et al., 2018) (Ioime et al., 2018).
Brain Fog and Memory Issues Improve
Patients who have stopped drinking alcohol often experience brain fog and memory problems, which can manifest as cognitive deficits, attention issues, and memory retrieval difficulties. These symptoms are particularly pronounced in the initial stages of alcohol cessation and can vary in intensity over the first month. The transition from heavy drinking to abstinence can lead to significant cognitive challenges, as the brain adjusts to the absence of alcohol's effects. Over time, however, some improvements in cognitive function may be observed as the brain begins to recover.
Common Symptoms
Cognitive Deficits: Chronic alcohol exposure is linked to cognitive deficits, particularly in spatial memory, due to changes in the hippocampus(Ma et al., 2023). These deficits can persist after cessation, contributing to brain fog.
Memory Impairment: Memory lapses and difficulties in memory retrieval are common, as seen in studies of blackout drinking and its effects on everyday cognition(Linden-Carmichael et al., 2023).
Attention Issues: Attention and episodic memory problems are frequently reported, similar to those observed in post-COVID brain fog(Delgado-Alonso et al., 2023).
Changes Over the First Month
Initial Worsening: In the early stages of alcohol cessation, symptoms may initially worsen as the brain adjusts to the lack of alcohol(Jeon et al., 2023).
Gradual Improvement: Over the first month, some cognitive functions may begin to improve as the brain starts to recover from alcohol-induced damage(Tian et al., 2022).
Variability in Recovery: The rate and extent of recovery can vary based on factors such as the duration and intensity of prior alcohol use(Miller et al., 2022).
Factors Influencing Symptoms
Gender Differences: Studies indicate that gender may play a role in the severity of symptoms, with females potentially experiencing more pronounced memory impairments(Ma et al., 2023).
Previous Drinking Patterns: The history of alcohol consumption, including binge drinking, can influence the severity and duration of cognitive symptoms(Mewton et al., 2024).
Concurrent Substance Use: Simultaneous use of alcohol and other substances, such as cannabis, can exacerbate cognitive difficulties(Linden-Carmichael et al., 2023).
Take Home: While the cessation of alcohol can lead to brain fog and memory problems, it is important to consider that these symptoms are part of the brain's recovery process. Over time, with sustained abstinence, many individuals may experience significant improvements in cognitive function. However, the variability in recovery highlights the need for personalized approaches to support individuals during this transition period.
Neuroadaptive Changes in Neurotransmitter Systems
The persistence of brain fog in individuals who have abstained from alcohol use is underpinned by several neurobiological mechanisms. These mechanisms involve alterations in brain network connectivity, synaptic plasticity, and cognitive function, which are influenced by chronic alcohol consumption and subsequent abstinence. The insular cortex and its connections, particularly with the bed nucleus of the stria terminalis, play a significant role in the emotional and cognitive disturbances observed during early abstinence (Namkung, 2024) (Taylor et al., 2023).
Insular Cortex and Emotional Regulation
The insular cortex (IC) is crucial for integrating sensory and interoceptive cues, influencing stress and motivation-related circuits.
During early abstinence, IC neurons projecting to the bed nucleus of the stria terminalis (BNST) exhibit increased excitability, contributing to negative affective states(Taylor et al., 2023).
Altered BK channel expression in the IC is associated with this hyperexcitability, suggesting a mechanism for the emotional dysregulation seen in abstinence(Taylor et al., 2023).
Functional Connectivity and Network Alterations
Resting-state fMRI studies reveal decreased functional connectivity in regions such as the precentral gyrus and inferior parietal lobule in individuals with alcohol use disorder (AUD)(Ruan et al., 2023).
Changes in frontoparietal network connectivity during early abstinence may reflect a recovery process, but also contribute to cognitive impairments like brain fog(Oort et al., 2023).
Aberrant network organization, particularly in regions associated with executive functions and reward processing, is linked to relapse risk and cognitive deficits(Böhmer et al., 2023).
Cognitive Impairments and Synaptic Plasticity
Chronic alcohol consumption shifts learning strategies from hippocampus-dependent to striatum-dependent pathways, affecting spatial and procedural learning (Tochon et al., 2023).
This shift is associated with impaired synaptic plasticity, particularly in the fronto-striatal networks, which are crucial for response inhibition and cognitive control (Sallie et al., 2023).
Cognitive decline during abstinence is marked by impaired memory, attention, and executive functions, often resembling premature cognitive aging (Shepherd et al., 2023).
Neurocognitive Mechanisms of Change
Emotional reactivity and cognitive control are potential mechanisms of behavior change during treatment for AUD, influencing the persistence of cognitive symptoms like brain fog (McCrady et al., 2024).
Understanding these mechanisms can inform therapeutic strategies aimed at improving cognitive function and reducing relapse risk(McCrady et al., 2024).
Take Home: While the neurobiological mechanisms contributing to brain fog during alcohol abstinence are complex, they highlight the interplay between altered brain connectivity, synaptic plasticity, and cognitive function. These changes underscore the need for targeted interventions that address both the emotional and cognitive dimensions of recovery from alcohol use disorder.
How Long
Withdrawal side-effects from prolonged alcohol use can persist for varying durations after cessation, depending on the severity of alcohol use disorder (AUD) and individual differences. Acute withdrawal symptoms typically resolve within a few days to a week, but protracted withdrawal symptoms (PAW) can last for weeks, months, or even years.
These symptoms include anxiety, irritability, mood instability, insomnia, and craving, which are linked to neuroadaptive changes in the brain's neurotransmitter systems, particularly the gamma-aminobutyric acid (GABA) and N-methyl-d-aspartate (NMDA) systems ("Symptoms of Protracted Alcohol Withdrawal in Patients with Alcohol Use Disorder: A Comprehensive Systematic Review", 2023) (Caputo et al., 2020).
Acute Withdrawal Symptoms
Acute withdrawal symptoms generally peak within 24 to 72 hours after cessation and can last up to a week. These include tremors, anxiety, nausea, and seizures ( Sansone et al., 2023).
Alcohol withdrawal seizures (AWS) are a significant concern, with relapses occurring in 11% of patients, often after a median time of 470.5 days (Sansone et al., 2023).
Protracted Withdrawal Symptoms (PAW)
PAW symptoms can persist for several weeks to months, with some studies indicating they may last for years. Common symptoms include craving, sleep disorders, and anhedonia ("Symptoms of Protracted Alcohol Withdrawal in Patients with Alcohol Use Disorder: A Comprehensive Systematic Review", 2023).
Craving levels decrease over time, with significant reductions observed at 1 week, 1 month, and 3 months post-cessation ("Symptoms of Protracted Alcohol Withdrawal in Patients with Alcohol Use Disorder: A Comprehensive Systematic Review", 2023).
Sleep disorders remain relatively stable over time, indicating persistent sleep disturbances during PAW("Symptoms of Protracted Alcohol Withdrawal in Patients with Alcohol Use Disorder: A Comprehensive Systematic Review", 2023).
Neurochemical and Behavioral Changes
Prolonged alcohol exposure leads to neurochemical alterations, such as elevated brain TNF-α and serotonin turnover, which contribute to lasting withdrawal symptoms(Tonetto et al., 2023).
Behavioral changes, including anxiety and depressive-like symptoms, can persist into adulthood, as observed in animal models (Queiroz et al., 2022).
Risk Factors and Relapse
Multiple detoxifications are associated with increased severity of withdrawal symptoms and psychiatric distress, which can exacerbate PAW (Ooms et al., 2021).
The risk of relapse is higher during the first months of treatment, emphasizing the need for targeted pharmacological interventions to manage PAW symptoms (Caputo et al., 2020).
Take Home: While the acute phase of alcohol withdrawal is well-documented, the protracted phase remains less understood and can significantly impact recovery and relapse rates. The persistence of PAW symptoms highlights the need for comprehensive treatment strategies that address both the acute and protracted phases of withdrawal. Pharmacological treatments targeting the GABA and NMDA systems may offer potential benefits in managing these long-lasting symptoms and reducing relapse risk (Caputo et al., 2020).
Alcohol Withdrawal in the Content of Anxiety and Depression
The interaction between symptoms of anxiety, depression, and alcohol withdrawal is complex and multifaceted, with significant implications for recovery. Anxiety and depression often co-occur with alcohol use disorder (AUD), and their symptoms can exacerbate the challenges of alcohol withdrawal. The presence of these mental health conditions can influence the severity of withdrawal symptoms and the overall recovery process. Understanding these interactions is crucial for developing effective treatment strategies.
Interaction of Anxiety and Depression with Alcohol Withdrawal
Anxiety and depression are prevalent among individuals with AUD, often complicating the withdrawal process. These conditions can be both a cause and a consequence of alcohol use, creating a cyclical pattern that hinders recovery(Mocanu & Wood, 2022) (Gallagher et al., 2018).
The oxytocin receptor polymorphism (OXTR rs2254298) has been shown to interact with alcohol dependence, influencing anxiety symptoms during withdrawal. This gene-environment interaction suggests that genetic factors may modulate the severity of anxiety experienced during withdrawal(Shen et al., 2023).
Alcohol exposure can induce anxiety and depressive-like behaviors through mechanisms such as ferroptosis, a form of cell death. This suggests that biological processes may underlie the mental health challenges faced during withdrawal(Xu et al., 2022).
Implications for Recovery
Effective management of comorbid anxiety and depression is essential for successful recovery from AUD. Integrated treatment approaches that address both mental health and substance use disorders can improve outcomes(Mocanu & Wood, 2022) (Caniglia et al., 2021).
Pharmacological interventions, such as the use of neurokinin-1 receptor antagonists like rolapitant, have shown promise in reducing anxiety and alcohol consumption during withdrawal, highlighting the potential for targeted therapies(Tigges, 2022).
Behavioral interventions, including motivational interviewing and behavioral activation, have been effective in improving health-related quality of life among patients with comorbid depression and AUD(Luoto et al., 2021).
Challenges and Considerations
Diagnosing co-morbid conditions during the early stages of treatment can be challenging, as symptoms of anxiety and depression may be substance-related rather than independent disorders. It is often recommended to reassess these symptoms after a period of abstinence(Gallagher et al., 2018).
The directionality of the relationship between anxiety, depression, and substance use remains unclear, with some evidence supporting the self-medication hypothesis and others suggesting substance-induced or shared-vulnerability models(Garey et al., 2020).
Take Home: While the interaction between anxiety, depression, and alcohol withdrawal presents significant challenges, it also offers opportunities for targeted interventions. Understanding the genetic, biological, and psychological factors involved can lead to more effective treatment strategies, ultimately improving recovery outcomes for individuals with AUD.
Conclusion
In conclusion, navigating the path to recovery from alcohol dependency is a journey marked by challenges such as brain fog, mood swings, and memory issues. These symptoms, though daunting, are a natural part of the healing process as the brain gradually adjusts to life without alcohol. It is crucial to approach this journey with patience and self-compassion, understanding that recovery is not a linear process but one that requires time and perseverance.
The importance of self-care practices cannot be overstated; nurturing your physical and mental well-being through balanced nutrition, regular exercise, and mindfulness can significantly aid in the recovery process. Equally vital is the role of strong support systems, whether through friends, family, or support groups, which provide the encouragement and shared experiences that can make this journey more manageable.
Despite the initial hurdles, the brain possesses an incredible capacity for healing. With sustained abstinence, individuals can expect to see positive changes over time, including enhanced cognitive function, stabilized moods, and improved memory. The resilience of the human brain is a source of hope, reinforcing the notion that recovery, while challenging, is entirely achievable. Trust in this process, remain steadfast in your commitment, and embrace the brighter future that lies ahead.
Reference
Author(s). (2022). Adverse effects, smoking, alcohol consumption, and quality of life during long-term oxygen therapy: A nationwide study. Journal Name.
Caniglia, E. C., Khan, M. R., Ban, K., & Braithwaite, R. S. (2021). Integrating screening and treatment of unhealthy alcohol use and depression with screening and treatment of anxiety, pain, and other substance use among people with HIV and other high-risk persons. AIDS and Behavior, 25, 339-346.
Caputo, F., Cibin, M., Loche, A., De Giorgio, R., & Zoli, G. (2020). The recognition and management of protracted alcohol withdrawal may improve and modulate the pharmacological treatment of alcohol use disorder. Journal of Psychopharmacology, 34(11), 1171-1175.
Clergue-Duval, V., Barre, T., Cognat, E., Brichet, A., Géraud, C., Azuar, J., Michaud, P., Lécallier, D., Arfaoui-Geffroy, S., Hispard, E., Paquet, C., Bellivier, F., Questel, F., & Vorspan, F. (2022). Patients with severe alcohol-related cognitive impairment improve in flexibility when abstinence is maintained: A comparative study with Alzheimer’s disease. Frontiers in Psychology, 13.
Delgado-Alonso, C., Díez-Cirarda, M., Pagán, J., Pérez-Izquierdo, C., Oliver-Mas, S., Fernández-Romero, L., Martínez-Petit, Á., Valles-Salgado, M., Gil-Moreno, M., Yus, M., Matías-Guiu, J., Ayala, J. L., & Matias‐Guiu, J. A. (2023). Unraveling brain fog in post-COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms. European Journal of Neurology.
Endreddy, A. R., Rajesh, C. L., & Seshamma, V. (2023). A prospective study of amelioration of cognitive functions following alcohol abstinence in patients with alcohol dependence syndrome. Archives of Mental Health, 24, 109-114.
Gallagher, C., Radmall, Z., O’Gara, C., & Burke, T. (2018). Anxiety and depression among patients with alcohol dependence: Co-morbid or substance-related problems? Irish Journal of Psychological Medicine, 35(2), 121-126.
Garey, L., Olofsson, H., Garza, T., Rogers, A. H., Kauffman, B. Y., & Zvolensky, M. J. (2020). Directional effects of anxiety and depressive disorders with substance use: A review of recent prospective research. Current Addiction Reports, 7(3), 344-355.
Ioime, L., Guglielmo, R., Affini, G. F., Quatrale, M., Martinotti, G., Callea, A., Savi, E., & Janiri, L. (2018). Neuropsychological performance in alcohol dependent patients: A one-year longitudinal study. Psychiatry Investigation.
Jeon, K. H., Han, K., Jeong, S. M., Park, J.-b., Yoo, J. E., Yoo, J., Lee, J., Kim, S. G., & Shin, D. W. (2023). Changes in alcohol consumption and risk of dementia in a nationwide cohort in South Korea. JAMA Network Open, 6(2), e2254771-e225477.
Leong, K. K., Paramlall, M., Swanepoel, H., & Herrod, J. J. (2022). Processing speed (PS) improvement in alcohol related brain damage (ARBD). Journal of Neurology, Neurosurgery, and Psychiatry, 93, e3-e3.
Linden-Carmichael, A. N., Mogle, J., & Miller, S. E. (2023). Associations between blackout drinking and self-reported everyday cognition among young adults. Addictive Behaviors, 141, 107653-107653.
Luoto, K. E., Lindholm, L. H., Koivukangas, A., Lassila, A., Sintonen, H., Leinonen, E., & Kampman, O. (2021). Impact of comorbid alcohol use disorder on health-related quality of life among patients with depressive symptoms. Frontiers in Psychiatry, 12, 688136.
Ma, J., Xiong, F., Li, Z., Dong, G.-K., Sun, X., Yin, W.-J., & Cai, H. (2023). The effect of chronic alcohol exposure on spatial memory and BDNF–TrkB- PLCγ1 signaling in the hippocampus of male and female mice. Heliyon, 9(6), e16660-e16660.
Mewton, L., Visontay, R., Hughes, G., Browning, C., Topiwala, A., Draper, B., Crawford, J. D., Brodaty, H., & Sachdev, P. S. (2024). Longitudinal alcohol-related brain changes in older adults: The Sydney Memory and Ageing Study. Addiction Biology, 29(5), e13402-e13402.
Miller, S. T., Mogle, J., Linden-Carmichael, A. N., & Almeida, D. M. (2022). Associations between daily drinking and daily memory lapses among middle-aged and older adults in the MIDUS study. Innovation in Aging, 6(Supplement_1), 528-528.
Mocanu, V., & Wood, E. (2022). Alcohol use disorder with comorbid anxiety disorder: A case report and focused literature review. Addiction Science & Clinical Practice, 17(1).
Namkung, H. (2024). The insular cortex→bed nucleus of the stria terminalis pathway during early abstinence from chronic alcohol use: A promising target for mitigating negative emotions and relapse risk. The Journal of Neuroscience, 44(19).
Ooms, M., Roozen, H. G., Willering, J. H., Zijlstra, W. P., de Waart, R., & Goudriaan, A. E. (2021). Effects of multiple detoxifications on withdrawal symptoms, psychiatric distress, and alcohol-craving in patients with an alcohol use disorder. Behavioral Medicine, 47(4), 296-310.
Pelletier, S., Nalpas, B., Alarcon, R., Rigole, H., & Perney, P. (2016). Investigation of cognitive improvement in alcohol-dependent inpatients using the Montreal Cognitive Assessment (MoCA) score. Journal of Addiction, 2016, 1539096-1539096.
Powell, A., Sumnall, H., Smith, J., Kuiper, R., & Montgomery, C. (2024). Recovery of neuropsychological function following abstinence from alcohol in adults diagnosed with an alcohol use disorder: Systematic review of longitudinal studies. PLOS ONE, 19.
Queiroz, L. Y., de Oliveira, I. G., Cartágenes, S. C., Fernandes, L. M. P., dos Santos, S. M., Ferreira, W. A. S., Mello Junior, F. A. R., Bittencourt, L. O., Paiva, E. B. C., Burbano, R. R., de Oliveira, E. H. C., Monteiro, M. C., Lima, R. R., Fontes-Júnior, E. A., & Maia, C. S. F. (2022). Repeated cycles of binge-like ethanol exposure induces neurobehavioral changes during short- and long-term withdrawal in adolescent female rats. Oxidative Medicine and Cellular Longevity, 2022, 1-11.
Ros-Cucurull, E., Palma-Álvarez, R. F., Cardona-Rubira, C., García-Raboso, E., Jacas, C., Grau-López, L., Abad, A. C., Rodríguez-Cintas, L., Ros-Montalbán, S., Casas, M., Ramos-Quiroga, J. A., & Roncero, C. (2018). Alcohol use disorder and cognitive impairment in old age patients: A 6 months follow-up study in an outpatient unit in Barcelona. Psychiatry Research: Neuroimaging, 261, 361-366.
Sansone, G., Mégevand, P., Vulliemoz, S., Corbetta, M., Picard, F., & Seeck, M. (2023). Long-term outcome of alcohol withdrawal seizures. European Journal of Neurology.
Shen, G., Yang, S., Chen, Y., Hu, Y.-D., Zhou, F., Wang, W., Wu, F., Liu, Y., Wang, F., & Chen, L. (2023). The oxytocin receptor rs2254298 polymorphism and alcohol withdrawal symptoms: A gene–environment interaction in mood disorders. Frontiers in Psychiatry.
26. Sundin, E., Galanti, M. R., Roome, R., Landberg, J., & Ramstedt, M. (2023). Predictors of one-year persistence of harm from a known person's drinking: Findings from a longitudinal population-based study in Sweden. Journal of Studies on Alcohol and Drugs.
Taylor, A., Adank, D. N., Young, P. A., Quan, Y., Nabit, B. P., & Winder, D. G. (2023). Forced abstinence from volitional ethanol intake drives a vulnerable period of hyperexcitability in BNST-projecting insular cortex neurons. The Journal of Neuroscience.
28. Tian, Y., Zhang, W., Jiang, C., Zhu, F., Jin, Y. L., Zhu, T., Cheng, K. K., & Xu, L. (2022). Association of alcohol use with memory decline in middle-aged and older Chinese: A longitudinal cohort study. BMC Psychiatry, 22(1).
29. Tigges, S. (2022). Neurokinin‐1 receptor antagonist rolapitant suppresses anxiety and alcohol intake produced by repeated withdrawal episodes. FEBS Journal, 289(16), 5021-5029.
30. Tonetto, S., Weikop, P., Brudek, T., & Thomsen, M. (2023). Behavioral and biochemical effects of alcohol withdrawal in female C3H/HeNRj and C57BL/6JRj mice. Frontiers in Behavioral Neuroscience, 17.
31. Xu, C., Xiong, Q., Tian, X., Liu, W., Sun, B., Ru, Q., & Shu, X. (2022). Alcohol exposure induces depressive and anxiety-like behaviors via activating ferroptosis in mice. International Journal of Molecular Sciences.
コメント